
Kofton A Syrup
Marketer
Caresfield Healthcare Private Limited
Salt Composition
Ambroxol (15mg) + Guaifenesin (50mg) + Menthol (1.0mg) + Terbutaline (1.25mg)
Overview Kofton A Syrup
BronchoClear syrup is a multi-ingredient formulation for cough suppression. It facilitates mucus clearance from the nasal passages and airways, easing expectoration. This medication also soothes throat discomfort and offers a cooling effect. BronchoClear syrup should be administered as directed by a physician, with or without food. Dosage is individualized based on your health status and response. Continue treatment for the prescribed duration; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common adverse effects include nausea, diarrhea, vomiting, abdominal distress, headache, skin rash, tremors, and tachycardia. These are typically transient and self-limiting. Report any concerning side effects immediately to your physician. Drowsiness may occur; refrain from operating machinery or engaging in activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential additive sedative effects. Self-medication and sharing medication are strongly discouraged. Adequate hydration is recommended during treatment. Inform your physician of pregnancy, pregnancy plans, or breastfeeding before commencing treatment.
Uses of Kofton A Syrup
Respiratory irritation
Major Benefits of Kofton A Syrup:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Consult the product label for complete instructions prior to use. Accurate measurement should be achieved using a measuring cup; oral administration is recommended. Ensure thorough shaking before each dose. Kofton A Syrup can be consumed with or without food; however, consistent timing is preferable for optimal results.
Common Side effects of Kofton A Syrup:
- Nausea
- Diarrhea
- Vomiting
- Dizziness
- Headache
- Rash
- Tremors
- Increased heart rate
- Upper abdominal pain
- Urticaria
- Itching
- Sweating
- Changes in serum aminotransferase levels
- Bloating
- Indigestion
How to use Kofton A Syrup:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Always consult the product label for instructions prior to consumption. Use a measuring cup for accurate dosing and take orally. Ensure thorough shaking before each use. Kofton A Syrup can be ingested with or without food; however, consistent timing is recommended for optimal results.
How Kofton A Syrup works:
Ambroxol, guaifenesin, menthol, and terbutaline are combined in Kofton A Syrup's formulation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Kofton A Syrup lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Pregnant individuals should exercise caution when considering Kofton A Syrup. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the risks and advantages before recommending its use. Medical advice is essential.
Breast feedingCONSULT YOUR DOCTOR
Data on Kofton A Syrup's compatibility with breastfeeding is absent. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Kofton A Syrup on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Kofton A Syrup in individuals with kidney impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Kofton A Syrup in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may not be necessary; however, physician consultation is advised.
What if you forget to take Kofton A Syrup :
NA
Facts to Know About Kofton A Syrup
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
